數位健康證據市場規模、佔有率和成長分析：按數位健康平台、最終用戶和地區分類 - 2026-2033 年產業預測

2024年全球數位健康證據市場價值為72億美元，預計將從2025年的88.3億美元成長到2033年的453.9億美元。預測期（2026-2033年）的複合年成長率預計為22.7%。

全球數位健康證據市場的主要驅動力是相關人員對可靠的真實世界數據的需求，這些數據能夠證明臨床效益和價值，並影響關鍵的採納和報銷決策。該領域專注於數據收集、分析和檢驗，以滿足監管標準，使開發商、支付方和醫療服務提供者能夠評估數位健康創新相關的安全性、有效性和成本效益。隨著支付方要求可驗證的價值，臨床醫生尋求可靠的指標來進行整合，該市場已發展為國家註冊系統和可操作性試驗。此外，監管機構和支付方在真實世界證據標準方面的合作有助於實現擴充性和可重複的結果。人工智慧的進步透過自動糾錯和異常檢測增強了數據檢驗，透過整合管治流程促進了可靠證據的生成，同時降低了成本並提高了研究準備度。

全球數位健康證據市場的促進因素

全球數位健康證據市場正受到遠端患者監護平台興起的顯著推動，這些平台能夠持續收集傳統醫療環境之外的健康數據。這種轉變增加了對專注於證據聚合、檢驗和決策支援工具的需求。這些創新提高了獲取真實世界患者數據的途徑，並能夠追蹤患者的長期預後，從而推動了醫療機構和技術供應商對數位證據解決方案的投資。此外，遠端監測與分析和臨床流程的無縫整合，增強了其價值提案，並推動了市場成長，因為相關人員正在尋求檢驗的證據，以用於確定治療路徑、報銷策略和營運效率。

全球數位健康證據市場的限制因素

由於對資料隱私和安全的日益關注，全球數位健康證據市場面臨許多限制因素。各機構的謹慎程度不斷提高，導致合規要求更加嚴格，採購流程也更加漫長。相關人員在評估必要的法律和技術保障措施時，往往會推遲投資，因為他們擔心病患隱私外洩的風險和潛在的資料外洩。此外，遵守各種法規結構和建立健全的管治也使供應商的發展變得更加複雜。這種複雜性阻礙了快速部署，限制了跨境數據共用，並最終減緩了數位健康證據解決方案在醫療保健系統中的擴充性和應用。

全球數位健康證據市場趨勢

全球數位健康證據市場日益關注互通性和生態系統整合，推動平台向能夠無縫交換臨床和營運資訊的平台轉型。這一趨勢凸顯了標準化介面和API驅動的工作流程的重要性，它們能夠簡化實施流程，最大限度地減少工作流程中斷，並最終促進從日常實踐中高效收集證據。隨著醫療生態系統內夥伴關係的不斷深化，協作式互通性測試變得至關重要，有助於提升相關人員之間的便利性和信任度。這種整合方法不僅為知情臨床路徑和報銷討論奠定了堅實的基礎，還有助於深入了解長期照護路徑，從而塑造數位健康的未來。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球數位健康證據市場規模：按數位健康平台和複合年成長率分類（2026-2033 年）

• 遠端醫療平台
• 穿戴式裝置

全球數位健康證據市場規模：按最終用戶和複合年成長率分類（2026-2033 年）

• 醫院和診所
• 運動員
• 其他

全球數位健康證據市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Epic Systems Corporation
• Cerner Corporation
• Allscripts Healthcare Solutions
• Medidata Solutions
• Health Catalyst
• Flatiron Health
• Omada Health
• WellDoc
• Pear Therapeutics
• Carrot Health
• HealthLoop
• Verily Life Sciences
• LifeQ
• Aetion
• Biofourmis
• Evidation Health
• Caresyntax
• MDLive
• Doximity
• Zocdoc

結論與建議

Global Digital Health Evidence Market size was valued at USD 7.2 Billion in 2024 and is poised to grow from USD 8.83 Billion in 2025 to USD 45.39 Billion by 2033, growing at a CAGR of 22.7% during the forecast period (2026-2033).

The global digital health evidence market is predominantly driven by healthcare stakeholders' demand for strong real-world data that illustrates clinical benefits and value, influencing crucial adoption and reimbursement decisions. This sector focuses on data collection, analytics, and regulatory-quality validation, enabling developers, payers, and providers to assess safety, effectiveness, and cost outcomes associated with digital health innovations. With payers requiring demonstrable value and clinicians seeking reliable indicators for integration, the market has evolved into national registries and pragmatic trials. Additionally, alignment between regulators and payers on real-world evidence standards promotes scalability and reproducible outcomes. Advancements in AI enhance data validation through automated error correction and anomaly detection, fostering more reliable evidence generation while lowering costs and enhancing study readiness through integrated governance processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Health Evidence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Health Evidence Market Segments Analysis

Global digital health evidence market is segmented by digital health platforms, end-user and region. Based on digital health platforms, the market is segmented into Telehealth Platforms and Wearable Devices. Based on end-user, the market is segmented into Hospitals and Clinics, Sportsman and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Health Evidence Market

The Global Digital Health Evidence market is significantly driven by the emergence of remote patient monitoring platforms, which allow for the ongoing collection of health data beyond conventional healthcare environments. This shift creates a heightened demand for tools focused on evidence aggregation, validation, and decision support. By improving access to real-world patient data and enabling the tracking of outcomes over time, these innovations encourage both healthcare organizations and technology vendors to invest in digital evidence solutions. Furthermore, the seamless integration of remote monitoring with analytics and clinical processes enhances their value proposition, propelling market growth as stakeholders pursue validated evidence to inform care pathways, reimbursement strategies, and operational effectiveness.

Restraints in the Global Digital Health Evidence Market

The global digital health evidence market faces significant constraints due to rising concerns surrounding data privacy and security. Organizations are becoming increasingly cautious, leading to stricter compliance requirements and extended procurement processes. When stakeholders are apprehensive about patient confidentiality risks and the potential for data breaches, they often postpone investments while assessing necessary legal and technical safeguards. Additionally, the necessity to adhere to various regulatory frameworks and establish strong governance complicates development for vendors. This complexity hinders quick deployment and limits cross-border data sharing, ultimately decelerating the scalability and adoption of digital health evidence solutions within health systems.

Market Trends of the Global Digital Health Evidence Market

The Global Digital Health Evidence market is increasingly focusing on interoperability and ecosystem integration, driving a significant shift towards platforms that facilitate the seamless exchange of clinical and operational information. This trend emphasizes the importance of standardized interfaces and API-driven workflows, which streamline implementations and minimize workflow disruptions, ultimately promoting efficient evidence aggregation from routine care. As partnerships within the healthcare ecosystem deepen, collaborative interoperability testing becomes vital, enhancing usability and fostering trust among stakeholders. This integrated approach not only strengthens the foundation for informed clinical pathways and reimbursement discussions but also nurtures insights into longitudinal care pathways, shaping the future of digital health.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Digital Health Evidence Market Size by Digital Health Platforms & CAGR (2026-2033)

• Market Overview
• Telehealth Platforms
• Wearable Devices

Global Digital Health Evidence Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Sportsman
• Others

Global Digital Health Evidence Market Size & CAGR (2026-2033)

• North America (Digital Health Platforms, End-User)
  • US
  • Canada
• Europe (Digital Health Platforms, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Digital Health Platforms, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Digital Health Platforms, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Digital Health Platforms, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellDoc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carrot Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthLoop
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verily Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aetion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evidation Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caresyntax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MDLive
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Doximity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zocdoc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations